Full Description
This book explores the potential of nanotechnology in treating metabolic disorders, highlighting its potential to improve drug delivery, early disease detection, and precision therapeutics. Metabolic syndrome is a significant global health challenge, with a five-fld increase in the risk of developing type-2 diabetes and a two-fold heightened risk of cardiovascular diseases. Despite advancements in understanding the pathogenesis of metabolic syndrome, current therapeutic interventions have not achieved optimal efficacy. The integration of nanotechnology into biomedicine is seen as a promising avenue to address this issue.
Nanoparticles can be engineered to carry anti-inflammatory agents, providing targeted relief at inflammation sites, reducing inflammation and minimizing systemic side effects. Nanotechnology also enhances drug delivery systems by navigating biological barriers and reaching specific sites with precision. This not only improves the bioavailability of therapeutic agents but also minimizes off-target effects, enhancing overall treatment effectiveness.
Nanotechnology also plays a pivotal role in early disease detection and diagnosis through innovative nano-imaging techniques. These techniques enable the visualization of molecular and cellular events at unprecedented resolutions, facilitating the identification of metabolic syndrome markers and associated disorders at their incipient stages. As research progresses, the integration of nanotechnology has the potential to redefine metabolic syndrome management, offering hope for improved patient outcomes and a healthier global population.
The chapters cover metabolic syndromes, including insulin resistance, hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, and non-alcoholic fatty liver disease. It provides up-to-date literature on mechanistic understanding and therapeutic strategies. It is a valuable resource for UG/PG students, clinicians, academicians, scientists, researchers, and industrial specialists in advanced materials science, flexible electronics, nanoelectronics, energy, environmental, and biomedical sciences.
Contents
.- Chapter 1: Introduction to Nanotheranostics and Metabolic Syndrome
.- Chapter 2: Pathophysiology Mechanism in Therapeutics of Metabolic Syndrome
.- Chapter 3: Phytochemical-Based Nanomedicine in the Treatment and Management of Metabolic Syndrome
.- Chapter 4: Role of Nano-biosensor in the diagnostics of metabolic syndrome
.- Chapter 5: Nanomaterials in Targeted Drug Delivery for Metabolic Syndrome
.- Chapter 6: Recent advances in nanotechnology-based approaches for diagnosis and treatment of metabolic syndrome
.- Chapter 7: Nanomaterials in Regulating Lipid Metabolism
.- Chapter 8: Cancer Nanotheranostics: Emerging strategies for diagnosis and therapeutics in cancer metabolism
.- Chapter 9: Polymer based hybrid nanomaterials for the treatment of metabolic syndrome
.- Chapter 10:Carbon-based Hybrid Nanomaterials for Treatment of Metabolic Syndrome
.- Chapter 11:Safety and Biocompatibility of Nanomaterials for Metabolic Syndrome
.- Chapter 12:Navigating the Future Landscape and Overcoming Challenges in Nanomaterials for Metabolic Syndrome
.- Chapter 13:3D Printed nanotechnology-based drug delivery in diagnosis and therapeutics of metabolic syndrome
.- Chapter 14:Ethical and Social Implications of Nanotechnology in the Management of Metabolic Syndrome
.- Chapter 15:Current prospective in nanotheranostics based therapy in neurometabolic disorder
.- Chapter 16:Recent Advances in Nanotheranostics-Based Personalized Medicine.
